Michael Berry

Michael Berry

Directeur Technique/Scientifique/R&D chez EVEREST MEDICINES LIMITED
61 ans
Health Technology
Consumer Services

Profil

Michael Berry is currently the Chief Technology Officer at Everest Medicines Ltd. He previously worked as the Senior Director of Bioprocess Development at Portola Pharmaceuticals, Director at ARCA biopharma, Director of Manufacturing Sciences & Technology at Novartis Vaccines & Diagnostics SL, and Vice President at Dynavax Technologies Corp.
He is also the Chief Technical Operations Officer at Clover Biopharmaceuticals Ltd. Berry received his undergraduate degree from De Montfort University, his graduate degree from The University of Manchester, and his doctorate from the University of Manitoba.

Postes actifs de Michael Berry

SociétésPosteDébut
EVEREST MEDICINES LIMITED Directeur Technique/Scientifique/R&D 15/06/2023

Anciens postes connus de Michael Berry

SociétésPosteFin
DYNAVAX TECHNOLOGIES CORPORATION Corporate Officer/Principal 01/08/2017
PORTOLA PHARMACEUTICALS, INC. Corporate Officer/Principal 01/02/2015
Novartis Vaccines & Diagnostics SL
Corporate Officer/Principal 01/09/2013
ARCA BIOPHARMA Directeur/Membre du Conseil 01/05/2009
CLOVER BIOPHARMACEUTICALS, LTD. Directeur Technique/Scientifique/R&D -
Voir l'expérience en détail de Michael Berry

Formation de Michael Berry

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

72

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées9

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Novartis Vaccines & Diagnostics SL

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Michael Berry
🔇